EDAP - Bathi resik saben saham (EPS TTM) EDAP Medical

Rising sales of Focal One robotic systems in the US provide EDAP TMS S.A. (EDAP) with powerful momentum. Leadership in minimally invasive urology is reinforced by the precision of ultrasound tumor ablation without surgical incisions. This 12-month net income per share chart captures these trends, with the current figure standing at -0.83. Business stability is anchored by a high-tech French plant with rigorous assembly quality control.

The scale of EDAP TMS S.A. (EDAP) operations is reflected in the trend of annual net income per share. This indicator measures real business efficiency by stripping the final financial result of the influence of the total number of securities. A trailing twelve-month calculation smooths out volatility, demonstrating the actual pace of capital generation. The steady growth of this metric confirms the success of the strategy to attract rare medical experts to the ultrasound therapy niche. Investors utilize this trend to determine the fundamental undervaluation of the asset.